Bridgeway Capital Management’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Bridgeway Capital Management’s Portfolio EDVA Stock Details EDVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-796	Closed	-$29.3K	–	1311
2024 Q2	$29.3K	Hold	796	–	–	﹤0.01%	1246
2024 Q1	$58.6K	Hold	796	–	–	﹤0.01%	1257
2023 Q4	$70.3K	Hold	796	–	–	﹤0.01%	1291
2023 Q3	$75.1K	Hold	796	–	–	﹤0.01%	1264
2023 Q2	$143K	Buy	796 +157	+25%	+$28.7K	﹤0.01%	1199
2023 Q1	$168K	Hold	639	–	–	﹤0.01%	1134
2022 Q4	$98.4K	Hold	639	–	–	﹤0.01%	1217
2022 Q3	$140K	Sell	639 -282	-31%	-$107K	﹤0.01%	1214
2022 Q2	$440K	Buy	921 +202	+28%	+$73K	0.01%	909
2022 Q1	$327K	Buy	+719	New	+$367K	0.01%	1047

Other funds holding EDVA

Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

SCTC

Sanibel Captiva Trust Company Sanibel, Florida $4.02B AUM 34.36% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Bridgeway Capital Management's EDVA Position: Q3 2024 in Review

Bridgeway Capital Management sold out of Endovia Health Sciences, Inc. (EDVA) in Q3 2024, closing a stake of 796 shares — an estimated $29.3K sold.

Bridgeway Capital Management first reported a position in EDVA in Q1 2022 and held it in 10 quarters. The position peaked at $440K in Q2 2022. 30 funds tracked by Wall St. Rank hold EDVA as of Q3 2024.

Bridgeway Capital Management reported no remaining Endovia Health Sciences, Inc. position as of Q3 2024 after selling out during the quarter.
Bridgeway Capital Management sold 796 Endovia Health Sciences, Inc. shares in Q3 2024, an estimated $29.3K.
Bridgeway Capital Management first reported a position in Endovia Health Sciences, Inc. in Q1 2022 and held it in 10 quarters.
Bridgeway Capital Management's Endovia Health Sciences, Inc. position peaked at $440K in Q2 2022.
30 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q3 2024.

Based on Bridgeway Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.